Abstract
ObjectiveTo describe the minimal disease activity (MDA) rate over time in patients with psoriatic arthritis (PsA) receiving antitumour necrosis factor agents, evaluate prognostic factors of MDA achievement and identify the...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have